Enrico Cortesi

Pubblicazioni

Titolo Pubblicato in Anno
Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO) ANNALS OF ONCOLOGY 2016
The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 2015
BRAFV600E mutation positive metastatic melanoma in a young woman treated with anti-BRAF/anti MEK combination: a case report JOURNAL OF TRANSLATIONAL MEDICINE 2015
Long-lasting complete response with trabectedin plu pegylated liposomal doxorubicin (PLD) in a young BRCA-mutated woman with platinum sensitive relapsed ovarian cancer (ROC) : a case report INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 2015
Extending the platinum-free interval (PFI) with Trabectedin plus Pegylated liposomal doxorubicin (PLD) in a patient with partially platinum sensitive (PPS) recurrent ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 2015
Clinical outcome and prognostic factors in renal medullary carcinoma: a pooled analysis from 18 years of medical literature CANADIAN UROLOGICAL ASSOCIATION JOURNAL 2015
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective analysis of progression-free (PFS) and overall survival (OS) in the “Real Life” ANNALS OF ONCOLOGY 2015
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective “Real Life” analysis of activity and safety EUROPEAN JOURNAL OF CANCER 2015
Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers: Patterns of Treatment and Costs. VALUE IN HEALTH 2015
Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment: results of an Italian multicentre study EUROPEAN UROLOGY 2015
The promise of liquid biopsy in cancer: a clinical perspective CHINESE JOURNAL OF CANCER RESEARCH 2015
E50Safety and toxicity in elderly patients in treatment for metastatic colon cancer ANNALS OF ONCOLOGY 2015
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest ANNALS OF ONCOLOGY 2015
The role of systemic chemotherapy Treatment of Peritoneal Surface Malignancies 2015

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma